MiMedx Group (NASDAQ: MDXG) reported Q3 EPS of $0.06, $0.01 better than the analyst estimate of $0.05. Revenue for the quarter came in at $49 million versus the consensus estimate of $48.61 million.

MiMedx Group sees Q415 revenue of $49.5-52.5 million, versus the consensus of $51.7 million.

MiMedx Group sees FY2015 revenue of $185-188 million, versus the consensus of $187.1 million.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.